Evidence map›Paper›PMID 20876093›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2010

Driving a wedge between viral lipids blocks infection.

Gregory B Melikyan

Open access · greenAbstract readComment
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Broad-spectrum antivirals against viral fusion.Nature reviews. Microbiology · 2015
    Review
  6. Article
  7. Flaviviruses: braking the entering.Current opinion in virology · 2013
    Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Gregory B MelikyanDepartment of Pediatrics Infectious Diseases, Emory University, Atlanta, GA 30322, USA.
Emory University · US

Funding

The Mechanism of Arenavirus Entry into CellsR01AI053668 · NIAID · UNIVERSITY OF MD BIOTECHNOLOGY INSTITUTE · PI MELIKIAN, GREGORY B · 2003 to 2023
$7.4M
BIOPHYSICS OF PROTEIN-MEDIATED MEMBRANE FUSIONR01GM054787 · NIGMS · UNIVERSITY OF MD BIOTECHNOLOGY INSTITUTE · PI MELIKIAN, GREGORY B · 2000 to 2018
$6.5M
Functional Characterization of the Hepatitis C Virus E1-E2 GlycoproteinsR21AI079714 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI MELIKIAN, GREGORY B · 2009 to 2010
$380k
NIAID NIH HHS AI053668NIAID NIH HHS R01 AI053668NIAID NIH HHS R21 AI079714NIAID NIH HHS R21AI079714NIGMS NIH HHS R01 GM054787NIGMS NIH HHS R01GM054787
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antiviral AgentsCell MembraneLipidsModels, BiologicalViral Fusion ProteinsVirus DiseasesVirusesVirus InternalizationVirus ReplicationAntiviral AgentsLipidsViral Fusion Proteins

Identifiers

PMID20876093
PMCPMC2951461
OpenAlexW2150597954

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.